|
|
| ADAM9_HUMAN |
ADAM9 |
Disintegrin and metalloproteinase domain-containing protein 9 |
8.238e-100 |
0.39
|
| OPRD_RAT |
Oprd1 |
Delta-type opioid receptor |
1.179e-84 |
0.48
|
| VHL_HUMAN |
VHL |
von Hippel-Lindau disease tumor suppressor |
4.724e-83 |
0.47
|
| OPRD_MOUSE |
Oprd1 |
Delta-type opioid receptor |
9.24e-80 |
0.48
|
| OPRM_RAT |
Oprm1 |
Mu-type opioid receptor |
5.556e-71 |
0.48
|
| AREG_HUMAN |
AREG |
Amphiregulin |
1.403e-70 |
0.34
|
| ELOB_HUMAN |
ELOB |
Elongin-B |
1.161e-59 |
0.33
|
| ELOC_HUMAN |
ELOC |
Elongin-C |
1.161e-59 |
0.33
|
| OPRM_CAVPO |
OPRM1 |
Mu-type opioid receptor |
3.43e-52 |
0.48
|
| NR1D1_HUMAN |
NR1D1 |
Nuclear receptor subfamily 1 group D member 1 |
1.542e-49 |
0.41
|
| Q8CGM4_CAVPO |
OPRM1 |
Mu-opioid receptor |
1.876e-45 |
0.45
|
| CFTR_HUMAN |
CFTR |
Cystic fibrosis transmembrane conductance regulator |
3.37e-45 |
0.43
|
| CAC1I_HUMAN |
CACNA1I |
Voltage-dependent T-type calcium channel subunit alpha-1I |
1.64e-39 |
0.39
|
| SENP2_HUMAN |
SENP2 |
Sentrin-specific protease 2 |
1.215e-35 |
0.28
|
| GRAB_HUMAN |
GZMB |
Granzyme B |
5.614e-27 |
0.34
|
| BAD_HUMAN |
BAD |
Bcl2-associated agonist of cell death |
6.171e-27 |
0.34
|
| MMP3_HUMAN |
MMP3 |
Stromelysin-1 |
2.141e-26 |
0.40
|
| BKRB2_RABIT |
BDKRB2 |
B2 bradykinin receptor |
2.296e-26 |
0.33
|
| OPRD_HUMAN |
OPRD1 |
Delta-type opioid receptor |
8.36e-26 |
0.48
|
| CAC1G_HUMAN |
CACNA1G |
Voltage-dependent T-type calcium channel subunit alpha-1G |
1.065e-25 |
0.39
|
| CAC1H_HUMAN |
CACNA1H |
Voltage-dependent T-type calcium channel subunit alpha-1H |
1.507e-25 |
0.39
|
| TM11D_HUMAN |
TMPRSS11D |
Transmembrane protease serine 11D |
4.1e-25 |
0.31
|
| CFAD_HUMAN |
CFD |
Complement factor D |
6.945e-25 |
0.44
|
| MC4R_MOUSE |
Mc4r |
Melanocortin receptor 4 |
1.839e-24 |
0.40
|
| MC3R_MOUSE |
Mc3r |
Melanocortin receptor 3 |
2.434e-24 |
0.40
|
| MMP8_HUMAN |
MMP8 |
Neutrophil collagenase |
3.613e-24 |
0.40
|
| P2RX7_HUMAN |
P2RX7 |
P2X purinoceptor 7 |
1.362e-22 |
0.41
|
| DHB3_HUMAN |
HSD17B3 |
Testosterone 17-beta-dehydrogenase 3 |
4.253e-22 |
0.35
|
| MEP50_HUMAN |
WDR77 |
Methylosome protein 50 |
6.063e-22 |
0.35
|
| ANM5_HUMAN |
PRMT5 |
Protein arginine N-methyltransferase 5 |
1.012e-21 |
0.35
|
| PPCE_MOUSE |
Prep |
Prolyl endopeptidase |
1.201e-21 |
0.30
|
| NAMPT_HUMAN |
NAMPT |
Nicotinamide phosphoribosyltransferase |
6.409e-21 |
0.36
|
| THRB_HUMAN |
F2 |
Prothrombin |
2.034e-20 |
0.48
|
| MC5R_MOUSE |
Mc5r |
Melanocortin receptor 5 |
3.095e-20 |
0.40
|
| HDAC8_HUMAN |
HDAC8 |
Histone deacetylase 8 |
3.85e-20 |
0.48
|
| Q9NAW4_PLAFA |
|
Cysteine protease falcipain-3 |
1.149e-19 |
0.31
|
| KCNJ6_HUMAN |
KCNJ6 |
G protein-activated inward rectifier potassium channel 2 |
1.474e-19 |
0.32
|
| MSHR_MOUSE |
Mc1r |
Melanocyte-stimulating hormone receptor |
8.266e-19 |
0.43
|
| BKRB1_RAT |
Bdkrb1 |
B1 bradykinin receptor |
3.658e-18 |
0.30
|
| ACE_HUMAN |
ACE |
Angiotensin-converting enzyme |
9.791e-18 |
0.41
|
| BCL2_HUMAN |
BCL2 |
Apoptosis regulator Bcl-2 |
1.759e-17 |
0.36
|
| TPP2_RAT |
Tpp2 |
Tripeptidyl-peptidase 2 |
1.797e-17 |
0.37
|
| PPCE_HUMAN |
PREP |
Prolyl endopeptidase |
1.11e-16 |
0.39
|
| AOFA_MOUSE |
Maoa |
Amine oxidase [flavin-containing] A |
3.331e-16 |
0.31
|
| FNTB_RAT |
Fntb |
Protein farnesyltransferase subunit beta |
5.551e-16 |
0.34
|
| FNTA_RAT |
Fnta |
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha |
6.661e-16 |
0.34
|
| KCNJ3_HUMAN |
KCNJ3 |
G protein-activated inward rectifier potassium channel 1 |
1.332e-15 |
0.32
|
| SCN3A_RAT |
Scn3a |
Sodium channel protein type 3 subunit alpha |
1.554e-15 |
0.30
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
7.216e-15 |
0.48
|
| ACE_RABIT |
ACE |
Angiotensin-converting enzyme |
5.362e-14 |
0.41
|
| KCNJ5_HUMAN |
KCNJ5 |
G protein-activated inward rectifier potassium channel 4 |
6.684e-14 |
0.32
|
| MMP1_HUMAN |
MMP1 |
Interstitial collagenase |
1.976e-13 |
0.39
|
| MC4R_HUMAN |
MC4R |
Melanocortin receptor 4 |
3.134e-13 |
0.47
|
| OGA_RAT |
Oga |
Protein O-GlcNAcase |
3.23e-13 |
0.29
|
| THRB_RAT |
F2 |
Prothrombin |
1.259e-12 |
0.30
|
| MMP9_HUMAN |
MMP9 |
Matrix metalloproteinase-9 |
1.378e-12 |
0.39
|
| CCKAR_CAVPO |
CCKAR |
Cholecystokinin receptor type A |
2.895e-12 |
0.31
|
| AGTR2_RAT |
Agtr2 |
Type-2 angiotensin II receptor |
5.22e-12 |
0.36
|
| SENP1_HUMAN |
SENP1 |
Sentrin-specific protease 1 |
6.384e-12 |
0.30
|
| CAN1_HUMAN |
CAPN1 |
Calpain-1 catalytic subunit |
1.887e-11 |
0.39
|
| XIAP_HUMAN |
XIAP |
E3 ubiquitin-protein ligase XIAP |
9.127e-11 |
0.39
|
| MTR1A_HUMAN |
MTNR1A |
Melatonin receptor type 1A |
1.417e-10 |
0.32
|
| MTR1B_HUMAN |
MTNR1B |
Melatonin receptor type 1B |
1.455e-10 |
0.32
|
| ASAH1_HUMAN |
ASAH1 |
Acid ceramidase |
1.514e-10 |
0.41
|
| AMP1_PLAFQ |
|
M1 family aminopeptidase |
1.539e-10 |
0.29
|
| Q6DMN0_TOXGO |
CPL |
Cathepsin L |
2.194e-10 |
0.30
|
| AROK_HELPY |
aroK |
Shikimate kinase |
4.011e-10 |
0.32
|
| ADA17_HUMAN |
ADAM17 |
Disintegrin and metalloproteinase domain-containing protein 17 |
5.146e-10 |
0.39
|
| SCN4A_HUMAN |
SCN4A |
Sodium channel protein type 4 subunit alpha |
6.93e-10 |
0.31
|
| SCN2A_HUMAN |
SCN2A |
Sodium channel protein type 2 subunit alpha |
8.163e-10 |
0.33
|
| MLX_HUMAN |
MLX |
Max-like protein X |
9.852e-10 |
0.28
|
| AMD_HUMAN |
PAM |
Peptidyl-glycine alpha-amidating monooxygenase |
1.496e-09 |
0.30
|
| OPRK_CAVPO |
OPRK1 |
Kappa-type opioid receptor |
1.68e-09 |
0.40
|
| MMP25_HUMAN |
MMP25 |
Matrix metalloproteinase-25 |
1.76e-09 |
0.30
|
| LUXS_ALIF1 |
luxR |
Transcriptional activator protein LuxR |
1.835e-09 |
0.34
|
| PPCE_PIG |
PREP |
Prolyl endopeptidase |
2.671e-09 |
0.37
|
| O60989_PLAVI |
|
Aspartic protease PM4 |
4.981e-09 |
0.28
|
| LIPE_HUMAN |
LIPG |
Endothelial lipase |
6.038e-09 |
0.39
|
| TYTR_TRYBB |
TPR |
Trypanothione reductase |
6.939e-09 |
0.30
|
| CATL1_BOVIN |
CTSL |
Cathepsin L1 |
1.804e-08 |
0.29
|
| PDE8A_HUMAN |
PDE8A |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A |
2.301e-08 |
0.31
|
| TRY1_BOVIN |
|
Cationic trypsin |
3.105e-08 |
0.31
|
| ATS4_HUMAN |
ADAMTS4 |
A disintegrin and metalloproteinase with thrombospondin motifs 4 |
3.955e-08 |
0.36
|
| CTBP2_HUMAN |
CTBP2 |
C-terminal-binding protein 2 |
4.778e-08 |
0.32
|
| ADA1B_MESAU |
ADRA1B |
Alpha-1B adrenergic receptor |
5.076e-08 |
0.34
|
| 5HT7R_HUMAN |
HTR7 |
5-hydroxytryptamine receptor 7 |
9.889e-08 |
0.34
|
| PANK3_HUMAN |
PANK3 |
Pantothenate kinase 3 |
1.576e-07 |
0.29
|
| CXCR3_HUMAN |
CXCR3 |
C-X-C chemokine receptor type 3 |
1.673e-07 |
0.42
|
| TS1R2_HUMAN |
TAS1R2 |
Taste receptor type 1 member 2 |
1.76e-07 |
0.32
|
| MC3R_HUMAN |
MC3R |
Melanocortin receptor 3 |
2.583e-07 |
0.32
|
| SPP2A_HUMAN |
SPPL2A |
Signal peptide peptidase-like 2A |
3.118e-07 |
0.28
|
| GASR_HUMAN |
CCKBR |
Gastrin/cholecystokinin type B receptor |
3.584e-07 |
0.31
|
| TS1R3_HUMAN |
TAS1R3 |
Taste receptor type 1 member 3 |
8.54e-07 |
0.32
|
| ADA1A_BOVIN |
ADRA1A |
Alpha-1A adrenergic receptor |
1.074e-06 |
0.34
|
| TAAR1_HUMAN |
TAAR1 |
Trace amine-associated receptor 1 |
1.956e-06 |
0.32
|
| Q6L5J4_HUMAN |
FPRL2 |
FML2_HUMAN |
2.018e-06 |
0.33
|
| OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
2.41e-06 |
0.37
|
| ITA4_HUMAN |
ITGA4 |
Integrin alpha-4 |
2.708e-06 |
0.34
|
| DCNL1_HUMAN |
DCUN1D1 |
DCN1-like protein 1 |
2.779e-06 |
0.30
|
| DRB3_HUMAN |
HLA-DRB3 |
HLA class II histocompatibility antigen, DR beta 3 chain |
2.965e-06 |
0.30
|
| Q2U7N3_ASPOR |
|
Beta-galactosidase |
3.596e-06 |
0.33
|
| ITB1_HUMAN |
ITGB1 |
Integrin beta-1 |
4.695e-06 |
0.34
|
| F16P1_HUMAN |
FBP1 |
Fructose-1,6-bisphosphatase 1 |
5.942e-06 |
0.37
|
| CATB_HUMAN |
CTSB |
Cathepsin B |
7.487e-06 |
0.35
|